Gladius Capital Management LP - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 229 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2024. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gladius Capital Management LP ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2024$31,943
-24.3%
992
-27.6%
0.00%
-42.9%
Q4 2023$42,169
+45.0%
1,370
+5.3%
0.01%
+600.0%
Q3 2023$29,078
+26.8%
1,301
+21.9%
0.00%0.0%
Q2 2023$22,930
-22.6%
1,067
-13.6%
0.00%
-50.0%
Q1 2023$29,628
-25.4%
1,235
-27.9%
0.00%
-33.3%
Q4 2022$39,742
+16.9%
1,713
-17.3%
0.00%
+200.0%
Q3 2022$34,0002,0710.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q2 2024
NameSharesValueWeighting ↓
Quantedge Capital Pte Ltd 291,400$9,383,0803.39%
Rubric Capital Management LP 2,333,500$75,138,7001.97%
Tejara Capital Ltd 124,700$4,015,3401.46%
Eventide Asset Management 2,634,656$84,835,9231.45%
THIRD AVENUE MANAGEMENT LLC 182,281$5,869,4481.01%
EMERALD MUTUAL FUND ADVISERS TRUST 530,456$17,080,6830.90%
EMERALD ADVISERS, LLC 650,173$20,935,5710.88%
SummerHaven Investment Management, LLC 34,773$1,119,6910.74%
Uniplan Investment Counsel, Inc. 146,375$4,7130.43%
Values First Advisors, Inc. 16,993$547,1690.33%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders